Femme et Homme
- | Pays :
- United States
- | Organes : -
- | Spécialités : -
Extrait
This study was designed to determine which immunosuppressive agent, rapamycin or mycophenalate mofetil, resulted in better outcome in patients with type 1 diabetes and renal failure, who presented for a kidney-pancreas transplant.
Critère d'inclusion
- Type 1 Diabetes